Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria

a case report and literature review

Takeshi Sato, Koji Muroya, Junko Hanakawa, Reiko Iwano, Yumi Asakura, Yukichi Tanaka, Kei Murayama, Akira Ohtake, Tomonobu Hasegawa, Masanori Adachi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pearson marrow-pancreas syndrome (PS) is a rare mitochondrial disorder. Impaired mitochondrial respiratory chain complexes (MRCC) differ among individuals and organs, which accounts for variable clinical pictures. A subset of PS patients develop 3-methylglutaconic aciduria (3-MGA-uria), but the characteristic symptoms and impaired MRCC remain unknown. Our patient, a girl, developed pancytopenia, hyperlactatemia, steatorrhea, insulin-dependent diabetes mellitus, liver dysfunction, Fanconi syndrome, and 3-MGA-uria. She died from cerebral hemorrhage at 3 years of age. We identified a novel 5.4-kbp deletion of mitochondrial DNA. The enzymatic activities of MRCC I and IV were markedly reduced in the liver and muscle and mildly reduced in skin fibroblasts and the heart. To date, urine organic acid analysis has been performed on 29 PS patients, including our case. Eight patients had 3-MGA-uria, while only one patient did not. The remaining 20 patients were not reported to have 3-MGA-uria. In this paper, we included these 20 patients as PS patients without 3-MGA-uria. PS patients with and without 3-MGA-uria have similar manifestations. Only a few studies have examined the enzymatic activities of MRCC. Conclusion: No clinical characteristics distinguish between PS patients with and without 3-MGA-uria. The correlation between 3-MGA-uria and the enzymatic activities of MRCC remains to be elucidated.• The clinical characteristics of patients with Pearson marrow-pancreas syndrome and 3-methylglutaconic aciduria remain unknown.• No clinical characteristics distinguish between Pearson marrow-pancreas syndrome patients with and without 3-methylglutaconic aciduria.

Original languageEnglish
Pages (from-to)1593-1602
Number of pages10
JournalEuropean Journal of Pediatrics
Volume174
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Electron Transport
Pancreas
3-Methylglutaconic Aciduria
VLCAD deficiency
Fanconi Syndrome
Steatorrhea
Electron Transport Complex I
Mitochondrial Diseases
Pancytopenia
Cerebral Hemorrhage
Type 1 Diabetes Mellitus
Mitochondrial DNA
Liver Diseases
Fibroblasts
Urine
Muscles
Skin

Keywords

  • 3-Methylglutaconic aciduria
  • Mitochondrial respiratory chain complexes
  • Organic aciduria
  • Pearson marrow-pancreas syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria : a case report and literature review. / Sato, Takeshi; Muroya, Koji; Hanakawa, Junko; Iwano, Reiko; Asakura, Yumi; Tanaka, Yukichi; Murayama, Kei; Ohtake, Akira; Hasegawa, Tomonobu; Adachi, Masanori.

In: European Journal of Pediatrics, Vol. 174, No. 12, 01.12.2015, p. 1593-1602.

Research output: Contribution to journalArticle

Sato, Takeshi ; Muroya, Koji ; Hanakawa, Junko ; Iwano, Reiko ; Asakura, Yumi ; Tanaka, Yukichi ; Murayama, Kei ; Ohtake, Akira ; Hasegawa, Tomonobu ; Adachi, Masanori. / Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria : a case report and literature review. In: European Journal of Pediatrics. 2015 ; Vol. 174, No. 12. pp. 1593-1602.
@article{f6efdf8961774d7faf9c5d604fa48051,
title = "Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review",
abstract = "Pearson marrow-pancreas syndrome (PS) is a rare mitochondrial disorder. Impaired mitochondrial respiratory chain complexes (MRCC) differ among individuals and organs, which accounts for variable clinical pictures. A subset of PS patients develop 3-methylglutaconic aciduria (3-MGA-uria), but the characteristic symptoms and impaired MRCC remain unknown. Our patient, a girl, developed pancytopenia, hyperlactatemia, steatorrhea, insulin-dependent diabetes mellitus, liver dysfunction, Fanconi syndrome, and 3-MGA-uria. She died from cerebral hemorrhage at 3 years of age. We identified a novel 5.4-kbp deletion of mitochondrial DNA. The enzymatic activities of MRCC I and IV were markedly reduced in the liver and muscle and mildly reduced in skin fibroblasts and the heart. To date, urine organic acid analysis has been performed on 29 PS patients, including our case. Eight patients had 3-MGA-uria, while only one patient did not. The remaining 20 patients were not reported to have 3-MGA-uria. In this paper, we included these 20 patients as PS patients without 3-MGA-uria. PS patients with and without 3-MGA-uria have similar manifestations. Only a few studies have examined the enzymatic activities of MRCC. Conclusion: No clinical characteristics distinguish between PS patients with and without 3-MGA-uria. The correlation between 3-MGA-uria and the enzymatic activities of MRCC remains to be elucidated.• The clinical characteristics of patients with Pearson marrow-pancreas syndrome and 3-methylglutaconic aciduria remain unknown.• No clinical characteristics distinguish between Pearson marrow-pancreas syndrome patients with and without 3-methylglutaconic aciduria.",
keywords = "3-Methylglutaconic aciduria, Mitochondrial respiratory chain complexes, Organic aciduria, Pearson marrow-pancreas syndrome",
author = "Takeshi Sato and Koji Muroya and Junko Hanakawa and Reiko Iwano and Yumi Asakura and Yukichi Tanaka and Kei Murayama and Akira Ohtake and Tomonobu Hasegawa and Masanori Adachi",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s00431-015-2576-7",
language = "English",
volume = "174",
pages = "1593--1602",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria

T2 - a case report and literature review

AU - Sato, Takeshi

AU - Muroya, Koji

AU - Hanakawa, Junko

AU - Iwano, Reiko

AU - Asakura, Yumi

AU - Tanaka, Yukichi

AU - Murayama, Kei

AU - Ohtake, Akira

AU - Hasegawa, Tomonobu

AU - Adachi, Masanori

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Pearson marrow-pancreas syndrome (PS) is a rare mitochondrial disorder. Impaired mitochondrial respiratory chain complexes (MRCC) differ among individuals and organs, which accounts for variable clinical pictures. A subset of PS patients develop 3-methylglutaconic aciduria (3-MGA-uria), but the characteristic symptoms and impaired MRCC remain unknown. Our patient, a girl, developed pancytopenia, hyperlactatemia, steatorrhea, insulin-dependent diabetes mellitus, liver dysfunction, Fanconi syndrome, and 3-MGA-uria. She died from cerebral hemorrhage at 3 years of age. We identified a novel 5.4-kbp deletion of mitochondrial DNA. The enzymatic activities of MRCC I and IV were markedly reduced in the liver and muscle and mildly reduced in skin fibroblasts and the heart. To date, urine organic acid analysis has been performed on 29 PS patients, including our case. Eight patients had 3-MGA-uria, while only one patient did not. The remaining 20 patients were not reported to have 3-MGA-uria. In this paper, we included these 20 patients as PS patients without 3-MGA-uria. PS patients with and without 3-MGA-uria have similar manifestations. Only a few studies have examined the enzymatic activities of MRCC. Conclusion: No clinical characteristics distinguish between PS patients with and without 3-MGA-uria. The correlation between 3-MGA-uria and the enzymatic activities of MRCC remains to be elucidated.• The clinical characteristics of patients with Pearson marrow-pancreas syndrome and 3-methylglutaconic aciduria remain unknown.• No clinical characteristics distinguish between Pearson marrow-pancreas syndrome patients with and without 3-methylglutaconic aciduria.

AB - Pearson marrow-pancreas syndrome (PS) is a rare mitochondrial disorder. Impaired mitochondrial respiratory chain complexes (MRCC) differ among individuals and organs, which accounts for variable clinical pictures. A subset of PS patients develop 3-methylglutaconic aciduria (3-MGA-uria), but the characteristic symptoms and impaired MRCC remain unknown. Our patient, a girl, developed pancytopenia, hyperlactatemia, steatorrhea, insulin-dependent diabetes mellitus, liver dysfunction, Fanconi syndrome, and 3-MGA-uria. She died from cerebral hemorrhage at 3 years of age. We identified a novel 5.4-kbp deletion of mitochondrial DNA. The enzymatic activities of MRCC I and IV were markedly reduced in the liver and muscle and mildly reduced in skin fibroblasts and the heart. To date, urine organic acid analysis has been performed on 29 PS patients, including our case. Eight patients had 3-MGA-uria, while only one patient did not. The remaining 20 patients were not reported to have 3-MGA-uria. In this paper, we included these 20 patients as PS patients without 3-MGA-uria. PS patients with and without 3-MGA-uria have similar manifestations. Only a few studies have examined the enzymatic activities of MRCC. Conclusion: No clinical characteristics distinguish between PS patients with and without 3-MGA-uria. The correlation between 3-MGA-uria and the enzymatic activities of MRCC remains to be elucidated.• The clinical characteristics of patients with Pearson marrow-pancreas syndrome and 3-methylglutaconic aciduria remain unknown.• No clinical characteristics distinguish between Pearson marrow-pancreas syndrome patients with and without 3-methylglutaconic aciduria.

KW - 3-Methylglutaconic aciduria

KW - Mitochondrial respiratory chain complexes

KW - Organic aciduria

KW - Pearson marrow-pancreas syndrome

UR - http://www.scopus.com/inward/record.url?scp=84948565214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948565214&partnerID=8YFLogxK

U2 - 10.1007/s00431-015-2576-7

DO - 10.1007/s00431-015-2576-7

M3 - Article

VL - 174

SP - 1593

EP - 1602

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 12

ER -